Prosecution Insights
Last updated: October 04, 2026
Application No. 19/349,565

SUTURE PASSER DEVICES, SYSTEMS, AND METHODS

Non-Final OA §102§112
Filed
Oct 03, 2025
Priority
May 31, 2024 — provisional 63/654,779 +1 more
Examiner
DANG, PHONG SON H
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Integrity Medical Services Inc.
OA Round
3 (Non-Final)
78%
Grant Probability
Favorable
3-4
OA Rounds
2y 3m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
541 granted / 694 resolved
+8.0% vs TC avg
Strong +25% interview lift
Without
With
+24.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
17 currently pending
Career history
711
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
44.4%
+4.4% vs TC avg
§102
30.9%
-9.1% vs TC avg
§112
17.9%
-22.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 694 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 21-40 is/are rejected under 35 U.S.C. 102(a)(2) as being anticipated by US 11/723,651 to Simon. Simon teaches: Claim 21: A suture passer device comprising: a body (Fig. 1B reproduced with annotation below); a first jaw member (Fig. 1B reproduced with annotation below) extending from the body, the first jaw member configured for angular movement relative to the body (Fig. 1B); and a second jaw member (Fig. 1B reproduced with annotation below) extending from the body, the second jaw member comprising: a curved portion (Fig. 1B reproduced with annotation below) extending from the body and curved away from the first jaw member, a straight portion (Fig. 1B reproduced with annotation below) extending from a distal end of the curved portion, wherein the curved portion is configured to offset the straight portion with respect to the body (Figs. 1A-1B); a tissue penetrator (Fig. 1B reproduced with annotation below) extending at least partially through the second jaw member, the tissue penetrator configured to shift between a retracted position and an engaged position (Figs. 1A-1B); and a trigger configured to actuate the first jaw member from an open position to a closed position, wherein the trigger is configured to actuate the tissue penetrator (Col. 14, II. 55-63 and claim 1, grasping and firing mechanism controlled with a proximate located trigger-handle) to the engaged position only when the first jaw member is in the closed position (see response to argument below). Claim 22: The tissue penetrator is a needle (180, Fig. 1B). Claim 23: A distal end of the needle (126, Fig. 1B) is curved toward the second jaw member in the engaged position, and wherein a radius of curvature of the needle is sized and shaped to avoid cartilage of a knee when the needle is actuated in a tissue of the knee (Functional limitation, the needle of Simon having the similar structural limitations of a radius and the needle tip is curved toward the second jaw as claimed, therefore, it would have performed the same function as claimed). Claim 24: The second jaw member (Fig. 1B reproduced with annotation below) comprises a shoulder (141, Fig. 2B) configured to direct the tissue penetrator toward the first jaw member. Claim 25: A suture loader (115, Fig. 2B) in the second jaw member. Claim 26: The suture loader (115) comprises a notch in the straight portion of the second jaw member. Claim 27: The suture loader (115) comprises a slot perpendicular to the notch and aligned with the tissue penetrator (the notch of 115 is the space running proximal to distal of the second jaw member, the slot is the space running from the inner surface of the second jaw member radially into the jaw, therefore it is perpendicular to one another, as shown in Fig. 2B, the slot is aligned with the needle curvature). Claim 28: A notch in the tissue penetrator (124, Fig. 1B) and a suture retainer (suture capture member 134, Fig. 2B), wherein the notch of the tissue penetrator is configured to capture a suture loop (Fig. 1B), the tissue penetrator is configured to move the suture loop through the first jaw member (Fig. 1B), and the suture retainer is configured to selectively retain the suture loop (suture capture member 134 configured to capture/retain the loop). Claim 29: The suture loop (Fig. 1B), the suture loop configured to be released from the suture retainer by pulling on an end of the suture loop (Functional limitation, the loop in Simon is capable of doing such). Claim 30: The notch of the tissue penetrator (124 Fig. 1B) is proximal to a distal end of the tissue penetrator (126, Fig. 1B). Claim 31: A suture passer device comprising: a body (Fig. 1B reproduced with annotation below); Page 5 a first jaw member (Fig. 1B reproduced with annotation below) extending from the body, the first jaw member configured for angular movement relative to the body; and a second jaw member (Fig. 1B reproduced with annotation below) extending from the body, the second jaw member comprising: a first portion (Fig. 1B reproduced with annotation below) extending from the body and away from the first jaw member, a second portion (Fig. 1B reproduced with annotation below) extending from a distal end of the first portion, wherein the first portion is configured to offset the second portion with respect to the body; and a needle (Fig. 1B reproduced with annotation below) extending at least partially through the second jaw member, the needle configured to shift between a retracted position (Fig. 1A) and an engaged position (Fig. 1B); and a trigger (Fig. 1B reproduced with annotation below) configured to actuate the first jaw member from an open position to a closed position, wherein the trigger is configured to actuate the needle (Col. 14, II. 55-63 and claim 1, grasping and firing mechanism controlled with a proximate located trigger handle) to the engaged position only when the first jaw member is in the closed position (see response to argument below). Claim 32: The first portion of the second jaw member is curved (Fig. 1B reproduced with annotation below). Claim 33: A distal end of the needle (126, Fig. 1B) is curved toward the second jaw member in the engaged position, and wherein a radius of curvature of the needle is sized and shaped to avoid cartilage of a knee when the needle is actuated in a tissue of the knee (Functional limitation, the needle of Simon having the similar structural limitations of a radius and the needle tip is curved toward the second jaw as claimed, therefore, it would have performed the same function as claimed). Claim 34: The second jaw member (Fig. 1B reproduced with annotation below) comprises a shoulder (141, Fig. 2B) configured to direct the tissue penetrator toward the first jaw member. Claim 35: A suture loader (115, Fig. 2B) in the second jaw member. Claim 36: The suture loader (115) comprises a notch in the second portion of the second jaw member. Claim 37: The suture loader (115) comprises a slot perpendicular to the notch and aligned with the tissue penetrator (the notch of 115 is the space running proximal to distal of the second jaw member, the slot is the space running from the inner surface of the second jaw member radially into the jaw, therefore it is perpendicular to one another, as shown in Fig. 2B, the slot is aligned with the needle curvature). Claim 38: A notch in the tissue penetrator (124, Fig. 1B) and a suture retainer (suture capture member 134, Fig. 2B), wherein the notch of the tissue penetrator is configured to capture a suture loop (Fig. 1B), the tissue penetrator is configured to move the suture loop through the first jaw member (Fig. 1B), and the suture retainer is configured to selectively retain the suture loop (suture capture member 134 configured to capture/retain the loop). Claim 39: The suture loop (Fig. 1B), the suture loop configured to be released from the suture retainer by pulling on an end of the suture loop (Functional limitation, the loop in Simon is capable of doing such). Claim 40: The notch of the tissue penetrator (124 Fig. 1B) is proximal to a distal end of the tissue penetrator (126, Fig. 1B). PNG media_image1.png 401 673 media_image1.png Greyscale Response to Arguments Applicant's arguments filed 08/10/2026 have been fully considered but they are not persuasive. The applicant argued that Simon fails to disclose a trigger that is prevented from actuating the tissue penetrator or needle to the engaged position when the jaws are open. This is not persuasive. Simon in Col. 14, II. 55-63 stated that the jaws are immobilize and stabilize the tissue, then the needle may be deployed by the trigger. Simon does not mention the needle being deployed when the jaws are in open configuration, just when the jaws are in closed configuration. Therefore, the examiner’s position is that the trigger configured to actuate the needle only the time the jaws are in closed configuration. Also, the claims do not recite that the needle is prevented from actuating the needle when the jaws are open. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHONG SON DANG whose telephone number is (571)270-5809. The examiner can normally be reached Mon-Fri 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at 571-272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PHONG SON H DANG/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Oct 03, 2025
Application Filed
Dec 09, 2025
Non-Final Rejection (signed) — §102, §112
Jan 20, 2026
Non-Final Rejection mailed — §102, §112
Apr 20, 2026
Response Filed
May 08, 2026
Final Rejection mailed — §102, §112
Aug 10, 2026
Request for Continued Examination
Aug 13, 2026
Response after Non-Final Action
Aug 25, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740778
KNOTLESS ALL SUTURE TISSUE REPAIR
1y 8m to grant Granted Sep 22, 2026
Patent 12740779
KNOTLESS ALL SUTURE TISSUE REPAIR
1y 8m to grant Granted Sep 22, 2026
Patent 12727878
SUTURE CLIP DEPLOYMENT DEVICES WITH SUTURE TENSIONING SYSTEMS
2y 8m to grant Granted Sep 08, 2026
Patent 12727874
FLEXIBLE SUTURING INSTRUMENT
2y 4m to grant Granted Sep 08, 2026
Patent 12721620
Suture Guiding Device
1y 8m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
78%
Grant Probability
99%
With Interview (+24.6%)
3y 3m (~2y 3m remaining)
Median Time to Grant
High
PTA Risk
Based on 694 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month